新型标记物可预测慢性乙型肝炎患者抗病毒治疗终止后的病

StephenW

  

Novel markers to predict virological and clinical relapse onset following antiviral treatment discontinuation in chronic hepatitis B patients                                                                           EASL 2020 Aug 27-29 virtual Reported by Jules Levin M.TUEFFERD1, M. CRABBE1, TH HU2, CY CHEN3, RN CHIEN4, KL WEI5, CY PENG6, WL CHUANG7, WW SU8, KH LIANG9,10, A SHEN1, YS LIN1, A DI CARA11, J BOLLEKENS1, CT YEH12, K SPITTAELS1, J AERSSENS1 1Janssen Pharmaceutica, Johnson & Johnson Pharmaceutical Research & Development 2Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan 3Chia-Yi Christian Hospital, Chia-Yi, Taiwan 4Linkou Chang Gung Memorial Hospital and University, Taoyuan, Taiwan 5Chiayi Chang-Gung Memorial Hospital, Chiayi, Taiwan 6China Medical University Hospital, Taichung, Taiwan 7Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 8Chang-Hua Christian Hospital, Chang-Hua, Taiwan 9Medical Research Department, Taipei Veterans General Hospital, Taipei, Taiwan 10Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan 11Precision for Medicine, Geneva, Switzerland 12Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan

StephenW

新型标记物可预测慢性乙型肝炎患者抗病毒治疗终止后的病毒学和临床复发发作


  EASL 2020 8月27-29日虚拟
朱尔斯·莱文报道

M.TUEFFERD1，M.CRABBE1，TH HU2，CY CHEN3，RN CHIEN4，KL WEI5，CY PENG6，WL CHUANG7，WW SU8，KH LIANG9,10，A SHEN1，YS LIN1，A DI CARA11，J BOLLEKENS1，CT YEH12， K SPITTAELS1，J AERSSENS1
1强生制药研究与开发公司（Janssen Pharmaceutica）2台湾高雄市高雄长庚纪念医院3台湾嘉义加义基督教医院4台湾桃园林口长庚纪念医院及大学5嘉义嘉义长庚纪念医院台湾6中国医科大学附属医院，台湾台中7台湾高雄医科大学附属医院，台湾高雄8台湾彰化中华医院长荣基督教医院，台湾台北9台北荣民总医院医学研究室10台湾林口长庚纪念医院肝脏研究中心台湾11瑞士日内瓦精密医学局12台湾林口长庚纪念医院肝脏研究中心